China Securities Co.Ltd(601066) about Tecon Biology Co.Ltd(002100)
Non public offering of a shares
of
Listing recommendation
Sponsor (lead underwriter)
December, 2001
China Securities Co.Ltd(601066)
About Tecon Biology Co.Ltd(002100)
Letter of recommendation for non-public offering of a shares
Shenzhen Stock Exchange:
With the approval of the reply on approving Tecon Biology Co.Ltd(002100) non-public development of shares (zjxk [2021] No. 1771) issued by the China Securities Regulatory Commission, Tecon Biology Co.Ltd(002100) (hereinafter referred to as ” Tecon Biology Co.Ltd(002100) “, “issuer” and “company”) non publicly issued 277449664 A-share shares to specific objects, with an issue price of 7.45 yuan / share and a total raised capital of 20669996.80 yuan (hereinafter referred to as “the company”) “This offering”). The sponsor of this offering is China Securities Co.Ltd(601066) (hereinafter referred to as ” China Securities Co.Ltd(601066) ” and “the sponsor”).
The sponsor believes that the issuer’s shares issued this time comply with the relevant provisions of the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the measures for the administration of securities issuance of listed companies, the detailed rules for the implementation of non-public offering of shares by listed companies and the stock listing rules of Shenzhen Stock Exchange, and hereby recommends that its shares be listed and traded in your exchange, The relevant information is reported as follows: I. Basic information of the issuer
(i) Issuer profile
Company name Tecon Biology Co.Ltd(002100)
English Name: teconbiology Co Ltd
Date of establishment: December 28, 2000
Listing date: December 26, 2006
Place of listing: Shenzhen Stock Exchange
Stock abbreviation Tecon Biology Co.Ltd(002100)
Stock Code: 002100 SZ
Legal representative: Yang Yan
Secretary of the board of directors Guo Yunjiang
The total share capital is 10763342 yuan
Registered address: No. 528, South Changchun Road, Urumqi high tech Industrial Development Zone, Xinjiang
Office address: No. 528, South Changchun Road, Urumqi high tech Industrial Development Zone, Xinjiang
Production and sales of veterinary drugs; Production and sales of feed; Production of additive premixed feed; Production and sales of feed additives; Sales of Holstein cattle (the specific business scope and validity period of the above projects shall be subject to the licenses issued by relevant departments); import and export of products and technologies within the business scope of self-supporting and acting as agents (except for goods and technologies limited or prohibited by the state); technical consulting services related to the business scope; sales of agricultural and livestock products; edible Shenzhen Agricultural Products Group Co.Ltd(000061) Sales of; Equity investment, sales of agricultural and sideline products; Production and sales of fertilizers; Warehousing. (for projects subject to approval according to law, business activities can be carried out only after approval by relevant departments)
The type of this securities issuance is non-public offering
Note: the total share capital of the company changes with the conversion of “Tiankang convertible bonds”. The total share capital of the company as of September 30, 2021 is listed here. According to the announcement on the conversion of convertible corporate bonds in the third quarter of 2021, as of September 30, 2021, the total share capital of the company was 1076334342 shares, and Tiankang convertible bonds were still listed for trading of RMB 88500000.
（2） Main financial data and financial indicators for the last three years
The audit institution xigma Certified Public Accountants (special general partnership) issued unqualified audit reports of xikuaishan Zi (2019) No. 1662, xikuaishan Zi (2020) No. 1172 and xikuaishan Zi (2021) No. 1580 on the issuer’s financial reports for 2018, 2019 and 2020 respectively.
Unless otherwise specified, the financial data of the last three years in this report are taken from the audit reports of 2018, 2019 and 2020 issued by Sigmar Certified Public Accountants (special general partnership). The financial data from January to September 2021 are unaudited.
1. Main data of consolidated balance sheet
Unit: 10000 yuan
Project September 30, 2021 December 31, 2020 December 31, 2019 December 31, 2018
Current assets: 795511.181069687.76669442.32585765.85
Non current assets 617048.14503241.60446004.09265108.37
Total assets: 1412559.321572929.361115446.41850874.22
Current liabilities 523088.96737193.58430095.54354660.02
Non current liabilities 250703.75148967.02168869.04168333.00
Total liabilities 773792.71886160.61598964.57522993.03
Attributable to the parent company
Owner’s right of the company: 563341.42623348.44459280.22320960.48
Total owner’s equity 638766.60686768.75516481.84327881.20
2. Main data of consolidated income statement
Unit: 10000 yuan
Project: January September 2021, 2020, 2019, 2018
Operating income 1232888.001198680.89747631.64527303.24
Operating profit -3672.71180813.1959068.4733322.84
Total profit -5775.75180773.1258992.8233441.40
Net profit -10119.73178530.5659239.2730105.76
Net profit attributable to shareholders of the parent company -19285.92172041.4564448.6731372.63
Net profit attributable to shareholders of the parent company after deduction of -16780.37172783.2563601.5329023.07
3. Main data of consolidated cash flow statement
Unit: 10000 yuan
Project: January September 2021, 2020, 2019, 2018
Net cash flow from operating activities 362930.24-60085.7430697.95-117844.16
Net cash flow from investment activities -124294.94-80641.15-136194.05-78910.22
Net cash flow from financing activities -156913.66150006.6493332.50225076.80
Balance of cash and cash equivalents at the end of the period 276764.41195042.77185763.01197926.61
4. Main financial indicators
Other major financial indicators of the company during the reporting period are as follows:
Financial index 2021.9 30/2020.12. 31/2019.12. 31/2018.12. 31 / January September 2021 2020 2019 2018
Current ratio (Times) 1.521.451.561.65
Quick ratio (Times) 0.950.630.840.95
Asset liability ratio (consolidated) 54.78% 56.34% 53.70% 61.47%
Asset liability ratio (parent company) 53.91% 44.34% 43.20% 54.26%
Turnover rate of accounts receivable (Times) 28.2537.8128.2525.56
Inventory turnover rate (Times) 2.391.812.002.45
Basic earnings per share (yuan / share) -0.181.610.600.33
Diluted earnings per share (yuan / share) -0.181.600.600.33
Note 1: current ratio = current assets / current liabilities; Quick ratio = (current assets inventory) / current liabilities; asset liability ratio = (total liabilities / total assets) × 100%； Turnover rate of accounts receivable = operating revenue / [(accounts receivable at the beginning of the period + accounts receivable at the end of the period) / 2];
Inventory turnover rate = operating cost / [(opening inventory + closing inventory) / 2].
Note 2: the financial indicators from January to September 2021 are not annualized.
2、 Issuance of shares applying for listing
The pricing benchmark date of this non-public offering is the first day of the issuance period, i.e. November 10, 2021. The issuing price of the non-public offering shall not be less than 80% of the average stock trading price of the 20 trading days before the pricing benchmark date (the average stock trading price of the 20 trading days before the pricing benchmark date = the total stock trading volume of the 20 trading days before the pricing benchmark date / the total stock trading volume of the 20 trading days before the pricing benchmark date), that is, not less than 7.43 yuan / share. 1. Stock type: RMB common stock (A shares)
2. Par value per share: RMB 1.00
3. Issuing method: non-public offering to specific investors
4. Issue price: 7.45 yuan / share
5. Number of shares issued: 277449664
6. Total funds raised: 2066999996.80 yuan
7. Net amount of raised funds: 2043263919.66 yuan
8. Issuing object, number of shares placed, amount of shares placed and share locking:
order
